Gender: All
Study Description:
This study is testing an investigational oral medication for hidradenitis suppurativa (HS), also known as acne inversa. Participants will receive one daily dose of either the study medication or a placebo for 16 weeks. Total participation will last approximately 6 months and would include 14 doctor’s visits throughout the study. Eligibility for the study will be determined by the study doctor following one or more in-person screening visits to the clinic. Trial-related procedures and study medication will be provided at no cost.

Qualifications:
- Must have lesions (lumps) present in at least 2 different areas of your body
- Cannot be currently receiving treatment for any other active inflammatory conditions

PROOF REQUIRED

Mailer Access: Key: https://www.affiliateaccesskey.com/m-dzkm-s96-a27a900bdc2238afa07618303ce04634
Optout Link: https://www.twonailhall.com/o-dzkm-s96-36e3b037ec63dddacb380e77d94ac832